|
331 |
Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial
Enthalten in BMC complementary and alternative medicine Bd. 17, 28.12.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
332 |
Excess adverse events during unblinded statin therapy
Enthalten in Reactions weekly Bd. 1651, 13.5.2017, Nr. 1, date:5.2017: 8
|
|
|
|
333 |
Exploring patients’ treatment journeys following randomisation in mental health trials to improve future trial conduct: a synthesis of multiple qualitative data sets
Enthalten in Trials Bd. 18, 15.6.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
334 |
Exploring the Diabetic Gastroparesis Patient Experience: Patient Exit Interviews
Enthalten in Advances in therapy Bd. 34, 27.10.2017, Nr. 12, date:12.2017: 2680-2692
|
|
|
|
335 |
Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial)
Enthalten in Trials Bd. 18, 6.3.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
336 |
Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial
Enthalten in Trials Bd. 18, 23.5.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
337 |
Fingolimod
Enthalten in Reactions weekly Bd. 1687, 3.2.2018, Nr. 1, date:2.2018: 97
|
|
|
|
338 |
First reports of adverse drug reactions
Enthalten in Drugs & therapy perspectives Bd. 33, 7.1.2017, Nr. 2, date:2.2017: 70-71
|
|
|
|
339 |
First reports of adverse drug reactions
Enthalten in Drugs & therapy perspectives Bd. 33, 6.3.2017, Nr. 4, date:4.2017: 181-182
|
|
|
|
340 |
First reports of adverse drug reactions
Enthalten in Drugs & therapy perspectives Bd. 33, 6.5.2017, Nr. 6, date:6.2017: 277-278
|
|
Administration
